Beneficient (NASDAQ:BENF – Get Free Report) released its quarterly earnings results on Monday. The company reported ($1.49) EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($1.64), Zacks reports. The company had revenue of ($14.40) million during the quarter, compared to analyst estimates of $13.10 million.
Beneficient Stock Down 0.6%
NASDAQ BENF opened at $0.62 on Tuesday. The firm’s 50-day simple moving average is $1.00 and its two-hundred day simple moving average is $2.83. Beneficient has a 52 week low of $0.50 and a 52 week high of $9.96.
Analysts Set New Price Targets
BENF has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Beneficient to a “hold” rating in a research report on Saturday, October 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Beneficient currently has a consensus rating of “Sell”.
Get Our Latest Research Report on Beneficient
Beneficient Company Profile
Beneficient is a financial services company focused on providing liquidity and related services for investors in alternative assets, such as interests in private equity and other private funds. These investments can be difficult to sell, and the company’s services are intended to help holders access liquidity without waiting for a fund’s full life cycle to end. The company offers financing and transaction solutions for alternative-asset holders, alongside trust, custody, and administrative services.
Read More
- Five stocks we like better than Beneficient
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
